Labetalol Hydrochloride NDC 60760-784

NDC codes

FDA NDC Directory

Product NDC (as listed)60760-784Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60760-0784Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60760-784-90	60760078490	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-784-90)Marketed from Oct 5, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Labetalol Hydrochloride
Generic name (nonproprietary): labetalol hydrochloride
Active ingredients: Labetalol hydrochloride — 100 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: St. Mary's Medical Park Pharmacy
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211953
Marketing start: Oct 5, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 60760-784_54d61630-01d9-0c4f-e063-6294a90a94e2SPL ID 54d61630-01d9-0c4f-e063-6294a90a94e2SPL set ID ed2293f8-2b82-c3db-e053-2995a90ad46cRxCUI 896758UNII 1GEV3BAW9J
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460760078490 followed by a unit qualifier and the quantity

Package 60760-0784-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 22, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Labetalol hydrochloride tablets USP are indicated in the management of hypertension. Labetalol hydrochloride tablets USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)